111 related articles for article (PubMed ID: 14518343)
1. [Liposome encapsulation of cystostatic drugs and starch microspheres improve tumor targeting in locoregional therapy. An animal experiment study of CC 531 liver tumor].
Berger G; Reszka R; Pohlen U; Jung M; Lucas S; Buhr HJ
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):693-7. PubMed ID: 14518343
[TBL] [Abstract][Full Text] [Related]
2. [Tumor regression in long-term follow-up by administration of liposome encapsulated 5-FU. An animal experiment in WAF rats with CC-531 liver tumor].
Pohlen U; Berger G; Jung M; Rezska R; Regenstein J; Buhr HJ
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):625-9. PubMed ID: 14518330
[TBL] [Abstract][Full Text] [Related]
3. Stealth liposomal 5-fluorouracil with or without degradable starch microspheres for hepatic arterial infusion in the treatment of liver metastases. An animal study in VX-2 liver tumor-bearing rabbits.
Pohlen U; Reszka R; Schneider P; Buhr HJ; Berger G
Anticancer Res; 2004; 24(3a):1699-704. PubMed ID: 15274343
[TBL] [Abstract][Full Text] [Related]
4. Hepatic arterial infusion in the treatment of liver metastases with PEG liposomes in combination with degradable starch microspheres (DSM) increases tumor 5-FU concentration. an animal study in CC-531 liver tumor-bearing rats.
Pohlen U; Reszka R; Buhr HJ; Berger G
Anticancer Res; 2011 Jan; 31(1):147-52. PubMed ID: 21273592
[TBL] [Abstract][Full Text] [Related]
5. Improvement of biodistribution with PEGylated liposomes containing docetaxel with degradable starch microspheres for hepatic arterial infusion in the treatment of liver metastases: a study in CC-531 liver tumor-bearing WAG RIJ rats.
Pohlen U; Buhr HJ; Berger G
Anticancer Res; 2011 Jan; 31(1):153-9. PubMed ID: 21273593
[TBL] [Abstract][Full Text] [Related]
6. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases.
Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C
Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433
[TBL] [Abstract][Full Text] [Related]
7. Repeated hepatic intra-arterial chemotherapy based on results of anticancer drug sensitivity test in patients with synchronous hepatic metastases from colorectal cancer.
Matsuoka H; Nagaya M; Tsukikawa S; Yanagi Y; Isogai A; Kubota S
Surgery; 2006 Sep; 140(3):387-95. PubMed ID: 16934600
[TBL] [Abstract][Full Text] [Related]
8. [Significant modification of the hyperthermic effect by starch microspheres (Spherex) of laser-induced hypertheria in the rat liver metastasis model].
Albrecht D; Germer CT; Pelz J; Isbert C; Ritz JP; Schuppan D; Buhr HJ
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):607-9. PubMed ID: 14518326
[TBL] [Abstract][Full Text] [Related]
9. Intra-aortal therapy with 5-fluorouracil- polyethylene glycol stealth liposomes: does the metabolism of 5-fluorouracil into 5-fluoro-2'-deoxyuridine depend on ph value?. An animal study in VX-2 liver tumor-bearing rabbits.
Pohlen U; Binnenhei M; Reszka R; Buhr HJ; Berger G
Chemotherapy; 2004 Jun; 50(2):67-75. PubMed ID: 15211080
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-2 as a modulator of 5-fluorouracil in hepatic arterial immunochemotherapy for liver metastases.
Okuno K; Hirai N; Takemoto Y; Kawai I; Yasutomi M
Hepatogastroenterology; 2000; 47(32):487-91. PubMed ID: 10791219
[TBL] [Abstract][Full Text] [Related]
11. Increased carboplatin concentration in liver tumors through temporary flow retardation with starch microspheres (Spherex) and gelatin powder (Gelfoam): an experimental study in liver tumor-bearing rabbits.
Pohlen U; Berger G; Binnenhei M; Reszka R; Buhr HJ
J Surg Res; 2000 Aug; 92(2):165-70. PubMed ID: 10896817
[TBL] [Abstract][Full Text] [Related]
12. Fluoropyrimidine chemotherapy in a rat model: comparison of fluorouracil metabolite profiles determined by high-field 19F-NMR spectroscopy of tissues ex vivo with therapy response and toxicity for locoregional vs systemic infusion protocols.
Lutz NW; Naser-Hijazi B; Koroma S; Berger MR; Hull WE
NMR Biomed; 2004 May; 17(3):101-31. PubMed ID: 15137037
[TBL] [Abstract][Full Text] [Related]
13. Vascular targeting agent Oxi4503 inhibits tumor growth in a colorectal liver metastases model.
Malcontenti-Wilson C; Chan L; Nikfarjam M; Muralidharan V; Christophi C
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e96-e104. PubMed ID: 17559382
[TBL] [Abstract][Full Text] [Related]
14. Spherex (degradable starch microspheres) chemo-occlusion--enhancement of tumor drug concentration and therapeutic efficacy: an overview.
Håkansson L; Håkansson A; Morales O; Thorelius L; Warfving T
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-100-S6-109. PubMed ID: 9151924
[TBL] [Abstract][Full Text] [Related]
15. Prediction of chemotherapeutic response of colorectal liver metastases with dynamic gadolinium-DTPA-enhanced MRI and localized 19F MRS pharmacokinetic studies of 5-fluorouracil.
van Laarhoven HW; Klomp DW; Rijpkema M; Kamm YL; Wagener DJ; Barentsz JO; Punt CJ; Heerschap A
NMR Biomed; 2007 Apr; 20(2):128-40. PubMed ID: 17006886
[TBL] [Abstract][Full Text] [Related]
16. Improvement in 5-fluorouracil (5-FU) and 5-fluoro-2'-deoxyuridine (FdUrd) concentration by 5-fluorouracil-polyethylene-glycol-liposomes in abdominal stop-flow: treatment of VX2 liver-tumor-bearing rabbits.
Pohlen U; Rieger H; Binnenhei M; Reszka RC; Buhr HJ; Berger G
J Chemother; 2005 Aug; 17(4):428-34. PubMed ID: 16167523
[TBL] [Abstract][Full Text] [Related]
17. Hepatic arterial infusion (HAI) with PEGylated liposomes containing 5-FU improves tumor control of liver metastases in a rat model.
Pohlen U; Buhr HJ; Berger G; Ritz JP; Holmer C
Invest New Drugs; 2012 Jun; 30(3):927-35. PubMed ID: 21360049
[TBL] [Abstract][Full Text] [Related]
18. An in vitro short time-high dose drug exposure assay for predicting 5FU-resistance of colorectal cancer.
Fan CW; Fan HA; Hsu SH; Chan CC; Chen SY; Hsu YH; Chan EC
Cancer Lett; 2004 Oct; 214(2):181-8. PubMed ID: 15363544
[TBL] [Abstract][Full Text] [Related]
19. Microprocessor-controlled iontophoretic drug delivery of 5-fluorouracil: pharmacodynamic and pharmacokinetic study.
Chandrashekar NS; Shobha Rani RH
J BUON; 2007; 12(4):529-34. PubMed ID: 18067212
[TBL] [Abstract][Full Text] [Related]
20. 5-Fluorouracil sensitive adenocarcinoma--a new experimental model in the rat.
Carlsson G; Larsson PA; Frösing R; Hafström LO; Spears CP; Peterson A; Gustavsson B
Anticancer Res; 1995; 15(2):433-9. PubMed ID: 7763018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
